IL151475A0 - Beadlets containing stavudine - Google Patents
Beadlets containing stavudineInfo
- Publication number
- IL151475A0 IL151475A0 IL15147501A IL15147501A IL151475A0 IL 151475 A0 IL151475 A0 IL 151475A0 IL 15147501 A IL15147501 A IL 15147501A IL 15147501 A IL15147501 A IL 15147501A IL 151475 A0 IL151475 A0 IL 151475A0
- Authority
- IL
- Israel
- Prior art keywords
- beadlets containing
- stavudine
- containing stavudine
- beadlets
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19358800P | 2000-03-30 | 2000-03-30 | |
PCT/US2001/010078 WO2001074329A2 (en) | 2000-03-30 | 2001-03-29 | Sustained release beadlets containing stavudine |
Publications (1)
Publication Number | Publication Date |
---|---|
IL151475A0 true IL151475A0 (en) | 2003-04-10 |
Family
ID=22714247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15147501A IL151475A0 (en) | 2000-03-30 | 2001-03-29 | Beadlets containing stavudine |
Country Status (26)
Country | Link |
---|---|
US (1) | US7135465B2 (xx) |
EP (1) | EP1267879A2 (xx) |
JP (1) | JP2003528905A (xx) |
KR (1) | KR20030011805A (xx) |
CN (1) | CN1187052C (xx) |
AR (1) | AR027748A1 (xx) |
AU (1) | AU2001249591A1 (xx) |
BG (1) | BG107157A (xx) |
BR (1) | BR0109602A (xx) |
CA (1) | CA2404687A1 (xx) |
CZ (1) | CZ20023003A3 (xx) |
EE (1) | EE200200564A (xx) |
GE (1) | GEP20043285B (xx) |
HU (1) | HUP0302631A2 (xx) |
IL (1) | IL151475A0 (xx) |
LT (1) | LT5045B (xx) |
LV (1) | LV12939B (xx) |
MX (1) | MXPA02009534A (xx) |
NO (1) | NO20024645L (xx) |
NZ (1) | NZ522250A (xx) |
PE (1) | PE20011179A1 (xx) |
PL (1) | PL366089A1 (xx) |
RU (1) | RU2239435C2 (xx) |
SK (1) | SK12822002A3 (xx) |
WO (1) | WO2001074329A2 (xx) |
ZA (1) | ZA200207760B (xx) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY169670A (en) | 2003-09-03 | 2019-05-08 | Tibotec Pharm Ltd | Combinations of a pyrimidine containing nnrti with rt inhibitors |
BR0312206A (pt) * | 2002-06-27 | 2005-04-12 | Cilag Ag | Formulações de pélete esférico |
WO2004112756A1 (en) | 2003-06-26 | 2004-12-29 | Isa Odidi | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
US8394409B2 (en) | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
US20060024361A1 (en) * | 2004-07-28 | 2006-02-02 | Isa Odidi | Disintegrant assisted controlled release technology |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
CN100548309C (zh) * | 2004-11-24 | 2009-10-14 | 东北制药总厂 | 司他夫定缓释片剂 |
TW201414495A (zh) | 2005-04-04 | 2014-04-16 | Tibotec Pharm Ltd | Hiv-感染之預防 |
EP1898890A1 (en) * | 2005-06-16 | 2008-03-19 | Forest Laboratories, Inc. | Modified and immediate release memantine bead formulation |
ES2352216T3 (es) * | 2005-08-31 | 2011-02-16 | Cipla Limited | Combinaciones farmacéuticas que contienen lamivudina, estavudina y nevirapina. |
GB0525461D0 (en) | 2005-12-15 | 2006-01-25 | Archimedes Dev Ltd | Pharmaceutical compositions |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
EP2007360B1 (en) | 2006-04-03 | 2014-11-26 | Isa Odidi | Controlled release delivery device comprising an organosol coat |
WO2007112579A1 (en) * | 2006-04-03 | 2007-10-11 | Isa Odidi | Drug delivery composition |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
AR065720A1 (es) | 2007-03-14 | 2009-06-24 | Tibotec Pharm Ltd | Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso. |
CN102319181B (zh) * | 2011-09-08 | 2014-07-16 | 广东大华农动物保健品股份有限公司 | 一种微囊型动物药品的包被工艺 |
US20140271893A1 (en) * | 2013-03-15 | 2014-09-18 | Mcneil-Ppc, Inc. | Coated phenylephrine particles and use thereof in pharmaceutical formulations |
BR112017000295A2 (pt) * | 2014-07-17 | 2017-11-07 | Dow Global Technologies Llc | dispersão e película de etilcelulose |
CN105511174A (zh) * | 2016-01-05 | 2016-04-20 | 深圳市华星光电技术有限公司 | 液晶显示面板和显示装置 |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4671963A (en) | 1983-10-28 | 1987-06-09 | Germino Felix J | Stearate treated food products |
US4670270A (en) | 1984-05-07 | 1987-06-02 | Germino Felix J | Stearate treated food products |
US4940556A (en) | 1986-01-30 | 1990-07-10 | Syntex (U.S.A.) Inc. | Method of preparing long acting formulation |
US4978655A (en) * | 1986-12-17 | 1990-12-18 | Yale University | Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses |
GB8707421D0 (en) * | 1987-03-27 | 1987-04-29 | Wellcome Found | Pharmaceutical formulations |
EP0619731B1 (en) | 1991-12-30 | 2000-10-04 | Fmc Corporation | Microcrystalline cellulose spheronization composition |
US5472711A (en) | 1992-07-30 | 1995-12-05 | Edward Mendell Co., Inc. | Agglomerated hydrophilic complexes with multi-phasic release characteristics |
US5723490A (en) | 1992-09-08 | 1998-03-03 | Vertex Pharmaceuticals Incorporated | THF-containing sulfonamide inhibitors of aspartyl protease |
FI101039B (fi) | 1992-10-09 | 1998-04-15 | Eeva Kristoffersson | Menetelmä lääkepellettien valmistamiseksi |
US5869097A (en) | 1992-11-02 | 1999-02-09 | Alza Corporation | Method of therapy comprising an osmotic caplet |
GB9403449D0 (en) | 1994-02-23 | 1994-04-13 | Wellcome Found | Therapeutic benzonitriles |
US6127372A (en) | 1994-03-07 | 2000-10-03 | Vertex Pharmaceuticals, Incorporated | Sulfonamide inhibitors of aspartyl protease |
CA2212525A1 (en) | 1995-02-23 | 1996-08-29 | Janssen Pharmaceutica N.V. | Use of fused benzothiazoles as neuroprotectants |
US6177460B1 (en) | 1995-04-12 | 2001-01-23 | The Procter & Gamble Company | Method of treatment for cancer or viral infections |
US5691372A (en) | 1995-04-19 | 1997-11-25 | Vertex Pharmaceuticals Incorporated | Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease |
US5914332A (en) | 1995-12-13 | 1999-06-22 | Abbott Laboratories | Retroviral protease inhibiting compounds |
AP9801258A0 (en) | 1995-12-15 | 1998-06-30 | Virodene Pharmaceutical Holdings Pty Ltd | Composition for organ cryopreservation and treatment of viral and bacterial infection |
SE9600072D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients II |
US5883252A (en) | 1996-01-26 | 1999-03-16 | Vertex Pharmaceuticals Incorporated | Aspartyl protease inhibitors |
US5766623A (en) | 1996-03-25 | 1998-06-16 | State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University | Compactable self-sealing drug delivery agents |
US5849911A (en) | 1996-04-22 | 1998-12-15 | Novartis Finance Corporation | Antivirally active heterocyclic azahexane derivatives |
US5780055A (en) | 1996-09-06 | 1998-07-14 | University Of Maryland, Baltimore | Cushioning beads and tablet comprising the same capable of forming a suspension |
US5905068A (en) | 1996-09-24 | 1999-05-18 | Abbott Laboratories | Retroviral protease inhibiting compounds |
CA2269707C (en) | 1996-10-25 | 2005-08-16 | Edward M. Rudnic | Soluble form osmotic dose delivery system |
US5962462A (en) | 1996-12-13 | 1999-10-05 | Merck & Co., Inc. | Spiro-substituted azacycles as modulators of chemokine receptor activity |
US5919776A (en) | 1996-12-20 | 1999-07-06 | Merck & Co., Inc. | Substituted aminoquinolines as modulators of chemokine receptor activity |
US6124319A (en) | 1997-01-21 | 2000-09-26 | Merck & Co., Inc. | 3,3-disubstituted piperidines as modulators of chemokine receptor activity |
US6136827A (en) | 1997-07-25 | 2000-10-24 | Merck & Co., Inc. | Cyclic amine modulations of chemokine receptor activity |
ES2234139T3 (es) | 1997-08-11 | 2005-06-16 | Alza Corporation | Forma de dosificacion de un agente activo de liberacion prolongada adaptada para la retencion gastrica. |
US6166037A (en) | 1997-08-28 | 2000-12-26 | Merck & Co., Inc. | Pyrrolidine and piperidine modulators of chemokine receptor activity |
US6692767B2 (en) * | 1997-09-19 | 2004-02-17 | Shire Laboratories Inc. | Solid solution beadlet |
US5904937A (en) | 1997-10-03 | 1999-05-18 | Fmc Corporation | Taste masked pharmaceutical compositions |
US6180634B1 (en) | 1997-11-13 | 2001-01-30 | Merck & Co., Inc. | Combination therapy for the treatment of AIDS |
US6013644A (en) | 1997-12-12 | 2000-01-11 | Merck & Co., Inc. | Spiro-substituted azacycles as modulators of chemokine receptor activity |
BR9813691A (pt) | 1997-12-19 | 2000-10-10 | Takeda Chemical Industries Ltd | Composição farmacêutica para antagonizar o ccr5, uso do composto ou um sal deste em combinação com um inibidor de protease e/ou um inibidor da transcriptase reversa, e, processo para antagonizar o ccr5. |
US6140349A (en) | 1998-02-02 | 2000-10-31 | Merck & Co., Inc. | Cyclic amine modulators of chemokine receptor activity |
US7122207B2 (en) * | 1998-05-22 | 2006-10-17 | Bristol-Myers Squibb Company | High drug load acid labile pharmaceutical composition |
US6093743A (en) | 1998-06-23 | 2000-07-25 | Medinox Inc. | Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
JP2002518452A (ja) | 1998-06-24 | 2002-06-25 | エモリ ユニバーシティ | Hivの治療薬物の製造のための他の抗hiv薬と組み合わせた3’−アジド−2’,3’−ジデオキシウリジンの使用 |
AU763431B2 (en) | 1999-03-31 | 2003-07-24 | Uaf Technologies And Research Llc | Viral treatment |
US6136835A (en) | 1999-05-17 | 2000-10-24 | The Procter & Gamble Company | Methods of treatment for viral infections |
-
2001
- 2001-03-29 PL PL01366089A patent/PL366089A1/xx not_active Application Discontinuation
- 2001-03-29 AU AU2001249591A patent/AU2001249591A1/en not_active Abandoned
- 2001-03-29 AR ARP010101516A patent/AR027748A1/es unknown
- 2001-03-29 BR BR0109602-8A patent/BR0109602A/pt not_active IP Right Cessation
- 2001-03-29 IL IL15147501A patent/IL151475A0/xx unknown
- 2001-03-29 CN CNB018074405A patent/CN1187052C/zh not_active Expired - Fee Related
- 2001-03-29 US US09/821,103 patent/US7135465B2/en not_active Expired - Lifetime
- 2001-03-29 SK SK1282-2002A patent/SK12822002A3/sk unknown
- 2001-03-29 EP EP01922832A patent/EP1267879A2/en not_active Withdrawn
- 2001-03-29 RU RU2002126540/15A patent/RU2239435C2/ru not_active IP Right Cessation
- 2001-03-29 NZ NZ522250A patent/NZ522250A/en unknown
- 2001-03-29 CA CA002404687A patent/CA2404687A1/en not_active Abandoned
- 2001-03-29 MX MXPA02009534A patent/MXPA02009534A/es not_active Application Discontinuation
- 2001-03-29 CZ CZ20023003A patent/CZ20023003A3/cs unknown
- 2001-03-29 WO PCT/US2001/010078 patent/WO2001074329A2/en not_active Application Discontinuation
- 2001-03-29 EE EEP200200564A patent/EE200200564A/xx unknown
- 2001-03-29 GE GEAP20016630A patent/GEP20043285B/en unknown
- 2001-03-29 KR KR1020027012769A patent/KR20030011805A/ko not_active Application Discontinuation
- 2001-03-29 JP JP2001572074A patent/JP2003528905A/ja active Pending
- 2001-03-29 HU HU0302631A patent/HUP0302631A2/hu unknown
- 2001-03-30 PE PE2001000297A patent/PE20011179A1/es not_active Application Discontinuation
-
2002
- 2002-09-06 LT LT2002099A patent/LT5045B/lt not_active IP Right Cessation
- 2002-09-26 ZA ZA200207760A patent/ZA200207760B/en unknown
- 2002-09-27 NO NO20024645A patent/NO20024645L/no not_active Application Discontinuation
- 2002-09-30 BG BG107157A patent/BG107157A/xx unknown
- 2002-10-25 LV LVP-02-187A patent/LV12939B/en unknown
Also Published As
Publication number | Publication date |
---|---|
PL366089A1 (en) | 2005-01-24 |
LT5045B (lt) | 2003-08-25 |
CZ20023003A3 (cs) | 2002-11-13 |
LV12939B (en) | 2003-04-20 |
BR0109602A (pt) | 2004-06-29 |
BG107157A (en) | 2003-06-30 |
LT2002099A (en) | 2003-04-25 |
WO2001074329A3 (en) | 2002-05-10 |
RU2002126540A (ru) | 2004-03-27 |
RU2239435C2 (ru) | 2004-11-10 |
JP2003528905A (ja) | 2003-09-30 |
EP1267879A2 (en) | 2003-01-02 |
US7135465B2 (en) | 2006-11-14 |
KR20030011805A (ko) | 2003-02-11 |
ZA200207760B (en) | 2004-01-30 |
NO20024645D0 (no) | 2002-09-27 |
AR027748A1 (es) | 2003-04-09 |
WO2001074329A2 (en) | 2001-10-11 |
SK12822002A3 (sk) | 2003-02-04 |
CA2404687A1 (en) | 2001-10-11 |
CN1187052C (zh) | 2005-02-02 |
US20020002147A1 (en) | 2002-01-03 |
NO20024645L (no) | 2002-09-27 |
AU2001249591A1 (en) | 2001-10-15 |
PE20011179A1 (es) | 2001-12-06 |
GEP20043285B (en) | 2004-07-26 |
HUP0302631A2 (hu) | 2003-11-28 |
MXPA02009534A (es) | 2003-05-14 |
EE200200564A (et) | 2004-06-15 |
NZ522250A (en) | 2004-09-24 |
CN1420774A (zh) | 2003-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3391801A (en) | Pyridinylimidazoles | |
GB0006432D0 (en) | Capsules | |
IL151475A0 (en) | Beadlets containing stavudine | |
AU8274301A (en) | Electro-powder | |
GB0016702D0 (en) | Expression system | |
AU4083801A (en) | Capsules | |
AU6619001A (en) | Liquid-pourers | |
GB0026363D0 (en) | Bi-endian libraries | |
AU4831301A (en) | Gm-negative ehv-mutants | |
IL152990A0 (en) | Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides | |
AU8756801A (en) | Thienopyrrolidinones | |
GB0030008D0 (en) | Brake limiting | |
GB0030980D0 (en) | Initial data | |
AU1852P (en) | Tickit xTriticosecale | |
AU1702P (en) | Trailblazer Xanthostemon chrysanthus | |
GB0000180D0 (en) | Myself | |
GB0021552D0 (en) | Capsule | |
GB0015961D0 (en) | Metamotion (3DMI) | |
GB0021252D0 (en) | Carbrola (outdoor-car-coverall-waterproof) | |
GB0020553D0 (en) | Concorde-Improvements (Shrapnel-shield) | |
GB0010360D0 (en) | Wrightclip (cliphandle) | |
GB0001291D0 (en) | Rescue-pump-resuscitator (foot-pump-resuscitator) | |
GB0016699D0 (en) | Expression system | |
LT2000056A (en) | Trijï laisv s laipsniï vartiklis | |
GB0020772D0 (en) | Simulator |